Literature DB >> 20415166

[Predictive factors of obstructive sleep apnea syndrome in obesity].

Sonia Maalej1, Samira Aouadi, Hatem Ben Moussa, Meherzia Bourguiba, Ali Ben Kheder, Ikram Drira.   

Abstract

BACKGROUND: Obstructive sleep apnea (OSA) syndrome is frequent, and misdiagnosed. THE AIM: Of this study is to assess the prevalence of OSA syndrome in a Tunisian population of obese (body mass index > or = 30 Kg/m2) and to determine its predictive factors.
METHODS: It's a transversal study. One hundred patients (63 females, 37 males) were inculded. All patients underwent nocturnal polysomnography or respiratory polygraphy.
RESULTS: Sixty-five patients had an OSA syndrome: mild (24.6%), moderate (30.7%) and severe (44.6%). We compared, by a statistical analysis, the group with OSA syndrome and the group without OSA syndrome. There was a predominance of men (81% of men vs 55.5 of women had OSA). Age was higher in the group with OSA syndrome (56.8 years +/- 10 vs 48.1 +/- 12, P = 0.04). Clinical symptoms such as snoring, daytime sleepiness, nocturnal awakening and respiratory pauses were more frequent in the group with OSA syndrome. Morphological abnormalities such as retrognathy and/or short neck were significantly more frequent in the group with OSA syndrome (p = 0.05 and 0.02 respectively). Cardiopathies and diabetes were more frequent in obese with OSA syndrome.
CONCLUSION: In obese persons, male gender, comorbidities and /or clinical symptoms such as snoring, daytime sleepiness, nocturnal awakening and respiratory pauses, retrognathy and/or short neck are predictive of OSA syndrome. So, we propose a nocturnal recording in obese presenting at least one of these predictive factors.

Entities:  

Mesh:

Year:  2010        PMID: 20415166

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  1 in total

1.  Treatment of tachycardia: bradycardia syndrome in a patient with obstructive sleep apnoea.

Authors:  Jakub Lagan; Palaniappan Saravanan
Journal:  BMJ Case Rep       Date:  2015-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.